FI921893A - Menetelmä terapeuttisesti käyttökelpoisten rapamysiinijohdannaisten valmistamiseksi anti-inflammatorisina ja antifungaalisina aineina - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten rapamysiinijohdannaisten valmistamiseksi anti-inflammatorisina ja antifungaalisina aineina Download PDF

Info

Publication number
FI921893A
FI921893A FI921893A FI921893A FI921893A FI 921893 A FI921893 A FI 921893A FI 921893 A FI921893 A FI 921893A FI 921893 A FI921893 A FI 921893A FI 921893 A FI921893 A FI 921893A
Authority
FI
Finland
Prior art keywords
inflammatory
preparation
antifungal agents
therapeutically useful
rapamycin derivatives
Prior art date
Application number
FI921893A
Other languages
English (en)
Swedish (sv)
Other versions
FI921893A0 (fi
FI97472C (fi
FI97472B (fi
Inventor
Philip Floyd Hughes
John Henry Musser
Craig Eugene Caufield
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/696,692 external-priority patent/US5102876A/en
Priority claimed from US07/741,714 external-priority patent/US5138051A/en
Application filed by American Home Prod filed Critical American Home Prod
Publication of FI921893A0 publication Critical patent/FI921893A0/fi
Priority to IE146592A priority Critical patent/IE921465A1/en
Publication of FI921893A publication Critical patent/FI921893A/fi
Application granted granted Critical
Publication of FI97472B publication Critical patent/FI97472B/fi
Publication of FI97472C publication Critical patent/FI97472C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI921893A 1991-05-07 1992-04-28 Menetelmä terapeuttisesti käyttökelpoisten rapamysiinijohdannaisten valmistamiseksi anti-inflammatorisina ja antifungaalisina aineina FI97472C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE146592A IE921465A1 (en) 1991-05-07 1992-07-01 Reduction products of rapamycin as immuno-suppressants,¹antiinflammatory of antifungal agents

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/696,692 US5102876A (en) 1991-05-07 1991-05-07 Reduction products of rapamycin
US69669291 1991-05-07
US74171491 1991-08-07
US07/741,714 US5138051A (en) 1991-08-07 1991-08-07 Rapamycin analogs as immunosuppressants and antifungals

Publications (4)

Publication Number Publication Date
FI921893A0 FI921893A0 (fi) 1992-04-28
FI921893A true FI921893A (fi) 1992-11-08
FI97472B FI97472B (fi) 1996-09-13
FI97472C FI97472C (fi) 1996-12-27

Family

ID=27105845

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921893A FI97472C (fi) 1991-05-07 1992-04-28 Menetelmä terapeuttisesti käyttökelpoisten rapamysiinijohdannaisten valmistamiseksi anti-inflammatorisina ja antifungaalisina aineina

Country Status (15)

Country Link
EP (1) EP0512754B1 (fi)
JP (1) JP3108192B2 (fi)
KR (1) KR100230877B1 (fi)
AT (1) ATE194352T1 (fi)
AU (1) AU647616B2 (fi)
DE (1) DE69231215T2 (fi)
DK (1) DK0512754T3 (fi)
ES (1) ES2147724T3 (fi)
FI (1) FI97472C (fi)
GR (1) GR3034033T3 (fi)
HU (1) HU217868B (fi)
MX (1) MX9202031A (fi)
NZ (1) NZ242616A (fi)
PH (1) PH30228A (fi)
PT (1) PT512754E (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776943A (en) * 1991-05-14 1998-07-07 American Home Products Corporation Rapamycin metabolites
US5118677A (en) * 1991-05-20 1992-06-02 American Home Products Corporation Amide esters of rapamycin
GB9302567D0 (en) * 1993-02-10 1993-03-24 Smithkline Beecham Plc Novel compound
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
JP3133922B2 (ja) 1995-06-09 2001-02-13 シャープ株式会社 強誘電体薄膜被覆基板、その製造方法、及びキャパシタ構造素子
JP3480624B2 (ja) 1995-06-09 2003-12-22 シャープ株式会社 強誘電体薄膜被覆基板、その製造方法、及びキャパシタ構造素子
EP0937082A2 (en) 1996-07-12 1999-08-25 Ariad Pharmaceuticals, Inc. Materials and method for treating or preventing pathogenic fungal infection
GB9826882D0 (en) 1998-12-07 1999-01-27 Novartis Ag Organic compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023262A (en) * 1990-08-14 1991-06-11 American Home Products Corporation Hydrogenated rapamycin derivatives

Also Published As

Publication number Publication date
DK0512754T3 (da) 2000-09-18
KR100230877B1 (ko) 1999-11-15
DE69231215T2 (de) 2000-11-09
KR920021553A (ko) 1992-12-18
FI921893A0 (fi) 1992-04-28
GR3034033T3 (en) 2000-11-30
NZ242616A (en) 1994-07-26
HU9201468D0 (en) 1992-07-28
JP3108192B2 (ja) 2000-11-13
FI97472C (fi) 1996-12-27
ES2147724T3 (es) 2000-10-01
DE69231215D1 (de) 2000-08-10
PH30228A (en) 1997-02-05
JPH05117279A (ja) 1993-05-14
MX9202031A (es) 1992-11-01
FI97472B (fi) 1996-09-13
EP0512754B1 (en) 2000-07-05
EP0512754A1 (en) 1992-11-11
HUT62589A (en) 1993-05-28
PT512754E (pt) 2000-11-30
HU217868B (hu) 2000-04-28
ATE194352T1 (de) 2000-07-15
AU1600892A (en) 1992-11-12
AU647616B2 (en) 1994-03-24

Similar Documents

Publication Publication Date Title
DE69223583D1 (de) Imidazolidyl-Makrolide mit immunosuppressiver Wirkung
FI942077A0 (fi) Monomeerisiä sappihappojohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina
YU89792A (sh) O-heteroaril, o-alkilheteroaril, o-alkenil-heteroaril i o-alkinilheteroaril makrolidi, o-h
IT1229570B (it) Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
NO304793B1 (no) nor-gallesyrederivater, og anvendelse av dem for fremstilling av legemiddel
CA2260777A1 (en) Pentafluorobenzenesulfonamides and analogs
DK0647219T3 (da) Derivater i vitamin D-serien modificeret i 20-positionen, fremgangsmåde til fremstilling af sådanne derivater, mellemprodukter itl brug ved fremgangsmåde, farmaceutiske præparater indeholdende derivaterne samt deres anvendelse ved fremstilling af lægemidler
NO305992B1 (no) Halvsyntetiske glykosaminglykosaner med heparin- eller heparanstruktur og fremgangsmåte til fremstilling derav
IT1223313B (it) Derivati di acidi biliari loro preparazione e composizioni farmaceutiche che li contengono
FI921893A (fi) Menetelmä terapeuttisesti käyttökelpoisten rapamysiinijohdannaisten valmistamiseksi anti-inflammatorisina ja antifungaalisina aineina
DK0587088T3 (da) Substituerede cyclohexan-derivater, fremgangsmåde til deres fremstilling og anvendelsen af forbindelserne til behandling af sygdomme
ATE13297T1 (de) Piperidyliden-derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
FI903706A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten syklosporiinijohdannaisten valmistamiseksi
IT1229569B (it) Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
HUT60458A (en) Process for producing benzyloxyphenyl derivatives and pharmaceutical compositions comprising same
IT1146726B (it) Derivati della 2 ossoazetidina loro produzione ed impiego
ATE154615T1 (de) Halbsynthetische glykosaminoglykane, die in 3- position mit nukleophilen radikalen substituierte alpha-l-galakturonsäure enthalten
ATE137223T1 (de) Leukotrien-b4-antagonisten
HUT59412A (en) Thieno/3,2-b/pyran-5,7-dione derivatives, process for their application and for the production of these compounds and their intermediates, as well as endoparasiticidal and herbicidal compositions comprising such compounds
DK177191D0 (da) Heterocyclic compounds and their preparation and use
FR2376151A1 (fr) Derives de pyrimidoquinoxaline, procede pour leur preparation et medicament contre l'asthme allergique contenant ces derives

Legal Events

Date Code Title Description
BB Publication of examined application
MA Patent expired